Biocept Stock

Biocept EBIT Margin

The EBIT Margin (Operating Margin) of Biocept (BIOCQ) as of Jul 12, 2026 is -123.67 %. In the previous year, EBIT Margin (Operating Margin) was -3.93 % — a change of 3,042.96% (lower).

EBIT Margin

-123.67 %

YoY

3,042.96%

Last updated:

EBIT Margin (Operating Margin) of Biocept is 2026 -123.67 % . EBIT Margin (Operating Margin) of Biocept was 2025 -3.93 % . It decreases by 3,042.96% lower compared to the previous year.

Biocept's operating (EBIT) margin stands at -123.7%, up from -746.5% several years earlier.

Access this data via the Eulerpool API

Biocept Stock analysis

What does Biocept do? Biocept is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biocept stock

EBIT Margin (Operating Margin) of Biocept is -123.67 % in 2026.

Access this data via the Eulerpool API

Margins — Biocept

All Key Metrics — Biocept